Investment Thesis:
- Increased demand for health care services due to ageing population of Australia, thereby contributing increased dependence on private health care insurers. NHF offers exposure to the business model of providing a funding mechanism for the high-growth health care sector.
- Healthcare expenditure is expected to rise by 5-10% per annum, so government cannot offer healthcare services to people without increase in tax.
- The average premium rates increased at the rate of 5 – 6% per annum.
- Policyholder growth and exposure to speed up the investments, NHF is expected to offer double-digit growth in medium term.
- Strong members in management.
- Chalking out budget plan, which improves the company’s expense ratio.
- PHI (Protected Health Information) is promoted by giving incentives and benefits.
- Joining with Tasly Holdings (Chinese Pharmaceutical Company) in Joint Venture and making international presence through the same.
Key Risks:
- Increase in competition among top 6 players
- Putting policy growth targets at risk
- Marketing expenses are anticipated to go high, thereby straining earnings growth.
- Unexpected decline in policyholders in spite of providing incentives
- Rapid increase in healthcare spending and health services demand from people have left Australian Government struggling.
- Registered health insurance firms are unable to increase premium rates without prior approval from the Government/Minister for Health/PHIAC/APRA. Because of this, NHF’s ROE and margins would be exposed to political process and pressures if the company makes large profits.
- Regulatory changes including tax incentives and benefits which encourage take up of PHI.
- Due to poor insurance policy design, aging population, and costs of new medical equipment, procedures and treatments; lapse rates and claims inflation would be higher than expected.
- Negotiations not done rightly with healthcare providers (private hospital operators) which may result into unfavorable contractual terms;
- Investment returns might be lower than expected.
Key Highlights:
- nib holdings Ltd. (NHF) reported strong FY21 results in spite of Covid-19, however it was in line with management expectations
- Revenue grew by +2.9% to $2.6bn and Group operating profit (UOP) of $204.9m, which is up by 39.5%
- NPAT of $160.5m was mainly driven by net investment income of $51.8m.
- Statutory EPS of 35.2 cents, which was +82.4% higher.
- ROIC of 19.1% which was similar to pre-pandemic levels.
- Final dividend of 14cps fully franked (up from 4 cents), which brings the full year dividend to 24cps.
Company Profile:
nib Holdings Limited (NHF) is the Australian private health insurer. NHF operates in four divisions which are private health insurance, life insurance, travel insurance and related health care activities.
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.